Biotest AG (Biotest AG) Interest Expense : $-42.7 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biotest AG's interest expense for the three months ended in Mar. 2024 was $ -13.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-42.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biotest AG's Operating Income for the three months ended in Mar. 2024 was $ 57.4 Mil. Biotest AG's Interest Expense for the three months ended in Mar. 2024 was $ -13.6 Mil. Biotest AG's Interest Coverage for the quarter that ended in Mar. 2024 was 4.22. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biotest AG Interest Expense Historical Data

The historical data trend for Biotest AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Interest Expense Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-11.89

-17.28

-14.92

-20.87

-43.62

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-13.92	-13.76	-13.02	-2.29	-13.59

Biotest AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.7 Mil.

Biotest AG (OTCPK:BIESF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biotest AG's Interest Expense for the three months ended in Mar. 2024 was $-13.6 Mil. Its Operating Income for the three months ended in Mar. 2024 was $57.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.0 Mil.

Biotest AG's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	57.391	/	-13.587
	=	4.22

The higher the ratio, the stronger the company's financial strength is.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.